NON-PSYCHOTROPIC CANNABINOIDS FOR PREVENTION OF COGNITIVE IMPAIRMENT

摘要

The present invention relates to pharmaceutical compositions comprising as an active ingredient non-psychotropic cannabinoids for preventing, alleviating or diminishing cognitive impairment resulting from certain types of surgery, diseases or viral infections, fetal distress, pre-term or low weight delivery, from medical intervention such as certain types of medication, irradiation or electroconvulsive therapy, or for prophylactic use in populations exhibiting mild cognitive impairment, at risk for chronic neurodegenerative diseases.